Skip to main content
Equibles

Corey Fishman

Board Member

Iterum Therapeutics plc (ITRMF)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Corey Fishman

Corey Fishman is recorded as Board Member at Iterum Therapeutics plc (ITRMF). Iterum Therapeutics plc reported in an 8-K filed March 27, 2026 that Corey Fishman resigned as President and Chief Executive Officer, effective March 27, 2026. Corey Fishman has spoken on 17 earnings calls across 1 company, most recently for Iterum Therapeutics plc on November 14, 2025.

“Also on March 27, 2026, each of Corey Fishman, the Company's President and Chief Executive Officer, and Judith Matthews, the Company's Chief Financial Officer, resigned from their positions with the Company, effective as of immediately following the filing of the Winding Up Petition.”
Iterum Therapeutics plc Form 8-K, filed March 27, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Iterum Therapeutics plc

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Show 6 earlier activities